Biocon Biologics Uk Plc
Clinical trials sponsored by Biocon Biologics Uk Plc, explained in plain language.
-
New biosimilar takes on keytruda in melanoma study
Disease control Not yet recruitingThis study tests whether a new drug called Bmab1800 works as well as the approved drug Keytruda for people with melanoma (a serious skin cancer) that has been removed by surgery. About 138 adults with stage IIB, IIC, or III melanoma will receive either Bmab1800 or Keytruda as an …
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New biosimilar aims to match opdivo in melanoma fight
Disease control Not yet recruitingThis study tests whether a new drug called Bmab1700 works like the approved drug Opdivo in people with melanoma (a serious skin cancer) after their tumor has been completely removed by surgery. The study will involve 120 adults with stage IIB to IV melanoma. The main goal is to c…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated May 13, 2026 16:03 UTC